Safety and feasibility of partial tubeless percutaneous nephrolithotripsy
-
摘要:
目的 探讨经皮肾镜碎石术部分无管化(PCNL)的安全性和临床疗效。 方法 选取安徽医科大学附属巢湖医院2021年1月—2023年6月收治的87例肾输尿管结石患者,按照手术方式分为传统经皮肾镜(留置肾造瘘管和双J管)手术组47例和经皮肾镜部分无管化(仅留置双J管)手术组40例。所有87例手术均由同一组医生完成,比较2组术前和围手术期资料,分析经皮肾镜手术并发症的影响因素。 结果 传统经皮肾镜手术组术后住院时间[7.00(6.00, 9.00)d vs. 5.00(4.00, 6.00)d]、首次下床时间[4.00(3.00, 5.00)d vs. 2.00(2.00, 3.00)d]、术后并发症发生率[17例(36.2%) vs. 3例(7.5%)]、术后VAS评分[7.00(7.00, 8.00)分vs. 5.00(5.00, 5.00)分]与经皮肾镜部分无管化手术组比较差异均有统计学意义(P < 0.05)。除性别外,2组术前年龄、BMI、STONE评分、术前尿白细胞、合并糖尿病、高血压、心脏病比较,差异均无统计学意义(P>0.05)。多因素分析显示,结石STONE评分与手术方式是术后并发症的独立影响因素。 结论 经皮肾镜部分无管化在手术安全性、术后VAS评分、术后恢复时间、住院时间、治疗费用、治疗效率方面具有显著优势,值得推广。 Abstract:Objective To investigate the safety and clinical efficacy of partial tubeless percutaneous nephrolithotripsy(PCNL). Methods A total of 87 patients with renal ureteral stones admitted to the Chaohu Hospital of Anhui Medical University between January 2021 to June 2023 were divided into 47 cases in the traditional percutaneous nephrolithotomy (with indwelling nephrostomy tube and double J-tube) surgical group and 40 cases in the percutaneous nephrolithotomy partially untubed (with indwelling double J-tube only) surgical group according to surgical methods. All 87 surgical procedures were performed by the same surgical team. The data pertaining to the preoperative and perioperative periods, along with the factors that may potentially influence the incidence factors that may potentially influence the incidence of complications associated with percutaneous nephrolithotomy were comparable between the two groups. Results In the traditional percutaneous nephroscopic surgery group, the postoperative hospitalization duration [7.00 (6.00, 9.00) d vs. 5.00 (4.00, 6.00) d], first time out of bed [4.00 (3.00, 5.00) d vs. 2.00 (2.00, 3.00) d], incidence of postoperative complications [17 cases (36.2%) vs. 3 cases (7.5%)] and postoperative VAS score [7.00 (7.00, 8.00) vs. 5.00 (5.00, 5.00)] were significantly different from those in the percutaneous nephroscopic partial tubeless surgery group (P < 0.05). With the exception of gender, the two groups exhibited statistically significant differences in preoperative age, BMI and STONE score. Preoperative urinary leukocytes, comorbidities of diabetes mellitus, hypertension, and cardiac disease did not reach statistical significance (P>0.05). A multifactorial analysis revealed that STONE score and surgical approach were independent risk factors for postoperative complications. Conclusion Percutaneous nephrolithotomy for partial tubelessness offers significant advantages in terms of surgical safety, postoperative VAS score, postoperative recovery time, average hospital stay, treatment cost, and treatment efficiency. It is therefore a procedure that merits further promotion. -
Key words:
- Percutaneous nephrolithotripsy /
- Partial actubation /
- Complications
-
表 1 2组肾输尿管结石患者一般资料比较
Table 1. Comparison of general data of patients with nephroureteral calculi in the two groups
组别 例数 年龄(x±s, 岁) 性别(例) BMI(x±s) Stone评分[M(P25, P75),分] 术前尿白细胞(例) 合并糖尿病(例) 合并高血压(例) 合并心脏病(例) 结石直径分类(例) 肾积水(例) 结石负荷(例) 男性 女性 <100个/μL ≥100个/μL <2 cm ≥2 cm 无 有 单发 多发 传统经皮肾镜组 47 54.72±12.23 36 11 24.32±3.29 7.00(6.00, 8.00) 35 12 5 6 1 17 30 20 27 9 38 部分无管化组 40 54.70±11.66 22 18 23.62±3.79 7.00(7.00, 8.00) 26 14 3 3 2 13 27 15 25 13 27 统计量 0.009a 4.535b 0.927a 968.000c 0.924b 0.255b 0.646b 0.535b 0.129b 0.229b 2.039b P值 0.993 0.033 0.356 0.804 0.358 0.721 0.498 0.592 0.720 0.666 0.216 注:a为t值,b为χ2值,c为Z值。 表 2 2组肾输尿管结石患者围手术期指标比较
Table 2. Comparison of perioperative indexes in the two groups of patients with renal ureteral calculi
组别 例数 手术时间(x±s, min) 术后血红蛋白下降量[M(P25, P75),g/L] 术后PCT[M(P25, P75),ng/mL] 术后住院时间[M(P25, P75),d] 传统经皮肾镜组 47 147.96±46.84 11.00(5.00, 18.00) 0.33(0.30, 0.60) 7.00(6.00, 9.00) 部分无管化组 40 115.63±36.29 9.50(4.00, 17.75) 0.30(0.30, 0.49) 5.00(4.00, 6.00) 统计量 3.551a 911.500b 860.500b 366.000b P值 0.001 0.808 0.482 <0.001 组别 例数 术后首次下床时间[M(P25, P75),d] 术后并发症[例(%)] 术后VAS评分[M(P25, P75),分] 术后焦虑(例) 术后睡眠时间(例) 术后有意义结石残留(例) 住院费用(x±s,元) <6 h ≥6 h 传统经皮肾镜组 47 4.00(3.00, 5.00) 17(36.2) 7.00(7.00, 8.00) 6 37 10 10 16 320±2 114 部分无管化组 40 2.00(2.00, 3.00) 3(7.5) 5.00(5.00, 5.00) 3 30 10 4 16 037±1 703 统计量 347.000b 10.033c 52.000b 0.646c 0.169c 2.035c 0.679a P值 <0.001 0.002 <0.001 0.498 0.681 0.154 0.499 注:a为t值,b为Z值,c为χ2值。 表 3 肾输尿管结石患者术后并发症影响因素的单因素分析
Table 3. Univariate analysis of influencing factors of postoperative complications in patients with renal ureteral calculi
变量 B SE Waldχ2 P值 OR值 95% CI 年龄 -0.013 0.021 0.368 0.544 0.987 0.947~1.029 性别 -0.868 0.613 2.000 0.157 0.420 0.126~1.398 BMI 0.047 0.071 0.443 0.506 1.049 0.912~1.206 Stone评分 0.634 0.214 8.772 0.003 1.885 1.239~2.867 手术时间 0.021 0.006 10.339 0.001 1.021 1.008~1.034 手术方式 1.944 0.673 8.354 0.004 6.989 1.870~26.122 糖尿病 0.122 0.859 0.020 0.887 1.130 0.210~6.088 高血压 -0.946 1.093 0.750 0.387 0.388 0.046~3.306 心脏病 -1.992 1.253 2.527 0.112 0.136 0.012~1.590 术前尿白细胞 0.003 0.003 0.598 0.439 1.003 0.996~1.009 注:各变量赋值如下,女性=1,男性=2;手术方式,传统经皮肾镜组=1,部分无管化组=2;无糖尿病=0,有糖尿病=1;无高血压=0,有高血压=1;无心脏病=0,有心脏病=1;无并发症=0,有并发症=1;其余连续性变量以实际值赋值。 表 4 肾输尿管结石患者术后并发症影响因素的多因素分析
Table 4. Multivariate analysis of influencing factors of postoperative complications in patients with renal ureteral calculi
变量 B SE Waldχ2 P值 OR值 95% CI Stone评分 0.507 0.237 4.554 0.033 1.660 1.042~2.644 手术时间 0.110 0.007 2.238 0.135 1.011 0.997~1.026 传统经皮肾镜/部分无管化经皮肾镜 1.596 0.719 4.924 0.026 4.931 1.205~20.186 -
[1] ABDRABUH A M I, GHANEM M M A, YAHIA M A A, et al. Reliability and validity of "S.T.O.N. E" nephrolithometry scoring system to predict the stone-free rate after percutaneous nephrolithotomy[J]. Urol Ann, 2021, 13(1): 14-18. [2] DESAI J, SHAH H N. Mini percutaneous kidney stone removal: applicable technologies[J]. Urol Clin North Am, 2022, 49(1): 161-173. doi: 10.1016/j.ucl.2021.08.003 [3] MAZZON G, CHOONG S, CELIA A. Stone-scoring systems for predicting complications in percutaneous nephrolithotomy: a systematic review of the literature[J]. Asian J Urol, 2023, 10(3): 226-238. doi: 10.1016/j.ajur.2023.01.005 [4] 彭剑, 郭文彬, 陈韬亦, 等. 腔内超声造影与常规超声引导经皮肾镜取石术治疗肾结石的Meta分析[J]. 中国内镜杂志, 2023, 29(4): 27-36.PENG J, GUO W B, CHEN T Y, et al. Meta-analysis of intracavitary contrast-enhanced ultrasound and conventional ultrasound-guided percutaneous nephrolithotomy in the treatment of kidney stones[J]. Chinese Journal of Endoscopy, 2023, 29(4): 27-36. [5] 张斌, 王翔. 超声与X线引导下经皮肾镜取石术治疗儿童复杂性肾结石的疗效及安全性比较[J]. 临床小儿外科杂志, 2020, 19(8): 683-687. doi: 10.3969/j.issn.1671-6353.2020.08.005ZHANG B, WANG X. Comparison of the efficacy and safety of ultrasound and X-ray guided percutaneous nephrolithotomy in the treatment of complicated kidney stones in children[J]. Journal of Clinical Pediatric Surgery, 2020, 19(8): 683-687. doi: 10.3969/j.issn.1671-6353.2020.08.005 [6] 张国银, 姜彦飞, 潘良朋, 等. 微创经皮肾镜碎石术与电子输尿管软镜术治疗肾结石的疗效对比研究[J]. 医药论坛杂志, 2022, 43(19): 45-48.ZHANG G Y, JIANG Y F, PAN L P, et al. Comparative study on the efficacy of minimally invasive percutaneous nephrolithotripsy and electronic ureteroscopy in the treatment of kidney stones[J]. Journal of Medical Forum, 2022, 43(19): 45-48. [7] 尹雪艳, 朱景香, 吴晓梦, 等. 输尿管软镜与经皮肾镜碎石术治疗肾结石疗效及对MDA和Cor水平的影响[J]. 医药论坛杂志, 2023, 44(18): 71-74.YIN X Y, ZHU J X, WU X M, et al. Effect of flexible ureteroscopy and percutaneous nephrolithotripsy in the treatment of renal calculi and its effect on MDA and Cor levels[J]. Journal of Medical Forum, 2023, 44(18): 71-74. [8] 黄裕棱, 李卓航, 刘成, 等. 斜跨位多通道经皮肾镜碎石术与单通道经皮肾镜联合输尿管软镜碎石术治疗鹿角形肾结石的疗效对比[J]. 中华医学杂志, 2021, 101(38): 3121-3126.HUANG Y L, Li Z H, LIU C, et al. Comparative effect of oblique translocation multi-channel percutaneous nephrolithotripsy and single channel percutaneous nephrolithotripsy combined with flexible ureteroscopy in the treatment of staghorn kidney stones[J]. Chinese Journal of Medicine, 2021, 101(38): 3121-3126. [9] 宋明泽, 唐寅. 经皮肾镜碎石取石术与经尿道输尿管软镜碎石取石术治疗肾结石的临床疗效对比[J]. 中华全科医学, 2021, 19(5): 753-755, 766. doi: 10.16766/j.cnki.issn.1674-4152.001908SONG M Z, TANG Y. Comparison of clinical efficacy of percutaneous nephrolithotomy and transurethral flexible ureteral lithotomy in the treatment of kidney stones[J]. Chinese Journal of General Practice, 2021, 19(5): 753-755, 766. doi: 10.16766/j.cnki.issn.1674-4152.001908 [10] 包鹏飞, 叶俊杰, 张会江. 超声引导经"肾椎体乳头-盏颈"穿刺在经皮肾镜碎石取石术中的安全性研究[J]. 浙江创伤外科, 2023, 28(10): 1807-1810.BAO P F, YE J J, ZHANG H J. Study on the safety of ultrasound-guided percutaneous nephrolithotomy through "renal vertebrae papillary-calyceal neck"[J]. Zhejiang Trauma Surgery, 2023, 28(10): 1807-1810. [11] 戚宇诚, 林方优, 李柏均, 等. 基于肾脏血管解剖建立经皮肾通道的临床研究[J]. 临床泌尿外科杂志, 2023, 38(1): 10-14.QI Y C, LIN F Y, LI B J, et al. Clinical study on the establishment of percutaneous renal channel based on renal vascular anatomy[J]. Journal of Clinical Urology, 2023, 38(1): 10-14. [12] 饶婷, 阮远, 程帆. 超声引导下经"肾盏穹隆-盏颈轴线"两步穿刺法: PCNL通道建立的解剖学研究及临床应用[J]. 现代泌尿外科杂志, 2021, 26(3): 185-188.RAO T, RUAN Y, CHENG F. Ultrasound guided two-step puncture through "calyceal dome-calyceal neck axis" : Anatomical study and clinical application of PCNL channel establishment[J]. Journal of Modern Urology, 2021, 26(3): 185-188. [13] 孙涛, 李良成, 王图超, 等. 经尿道输尿管软镜碎石术与经皮肾镜碎石术治疗肾结石的比较研究[J]. 贵州医药, 2022, 46(9): 1453-1455.SUN T, LI L C, WANG T C, et al. Comparative study of transurethral flexible ureteral lithotripsy and percutaneous nephrolithotripsy in the treatment of kidney stones[J]. Guizhou Medicine, 2022, 46(9): 1453-1455. [14] 许凯豪, 宋梦瑶, 焦德超, 等. Histoacryl组织胶超选择性栓塞肾动脉分支治疗医源性肾动脉出血[J]. 中国介入影像与治疗学, 2022, 19(8): 449-453.XU K H, SONG M Y, JIAO D C, et al. Treatment of iatrogenic renal artery hemorrhage by hyperselective embolization with Histoacryl adhesive[J]. Chinese Journal of Interventional Imaging and Therapeutics, 2022, 19(8): 449-453. [15] 窦全亮, 周六化, 李荣飞, 等. 直视下双导丝扩张法: 一种建立经皮肾通道的新方式[J]. 现代泌尿外科杂志, 2023, 28(11): 980-983.DOU Q L, ZHOU L H, LI R F, et al. Double guide wire dilation under direct vision: a new approach to establish percutaneous renal channel[J]. Journal of Modern Urology, 2023, 28(11): 980-983. [16] 张英晨, 赵帅, 孙浩, 等. 局麻下非同步CT辅助联合超声定位微创经皮肾镜取石术治疗上尿路结石的效果[J]. 山东大学学报(医学版), 2023, 61(10): 46-50, 57.ZHANG Y C, ZHAO S, SUN H, et al. Effect of non-synchronous CT assisted minimally invasive percutaneous nephrolithotomy under local anesthesia in the treatment of upper urinary tract stones[J]. Journal of Shandong University (Medical Science Edition), 2023, 61(10): 46-50, 57. [17] 黄锐, 陈新华. 基于CT, 三维重建技术的不同穿刺路径对经皮肾穿刺肾上盏的安全性研究[J]. 泌尿外科杂志(电子版), 2022, 14(1): 22-25.HUANG R, CHEN X H. Study on the safety of percutaneous renal puncture of upper calicae by different puncture paths based on CT+ 3D reconstruction[J]. Journal of Urology, 2022, 14(1): 22-25. [18] 陈忠华, 林志根, 彭士彬, 等. 部分无管化与留置肾造瘘管经皮肾镜碎石术治疗上尿路结石患者的效果比较[J]. 中国民康医学, 2021, 33(22): 154-155, 158.CHEN Z H, LIN Z G, PENG S B et al. Comparison of the effect of percutaneous nephrolithotripsy with partial tubeless and indwelling nephrostomy in the treatment of upper urinary tract stones[J]. Chinese Journal of Medical Sciences, 2021, 33(22): 154-155, 158. [19] 黄旭锋, 杨水法, 洪德时, 等. 对比分析部分无管化与留置肾造瘘管经皮肾镜碎石术治疗上尿路结石的临床效果[J]. 中外医疗, 2023, 42(19): 96-99.HUANG X F, YANG S F, HONG D S et al. To compare and analyze the clinical effect of percutaneous nephrolithotripsy with partial catheterization and indwelling nephrostomy in the treatment of upper urinary tract stones[J]. Chinese and foreign medical treatment, 2023, 42(19): 96-99. [20] 何祥彪, 刘杨洋, 杜丹, 等. 部分无管化与标准经皮肾镜取石术治疗上尿路结石的有效性及安全性[J]. 现代泌尿外科杂志, 2023, 28(6): 516-518, 528.HE X B, LIU Y Y, DU D, et al. Efficacy and safety of partial tubeless and standard percutaneous nephrolithotomy in the treatment of upper urinary tract stones[J]. Journal of Modern Urology, 2023, 28(6): 516-518, 528. [21] 周剑芳, 高诚, 阳东荣. S.T.O.N.E. 评分与肾结石经皮肾镜术后清石率及并发症的相关性分析[J/CD]. 中华腔镜泌尿外科杂志(电子版), 2020, 15(2): 121-125.ZHOU J F, GAO C, YANG D R. Correlation analysis of S.T.O.N.E. score with stone removal rate and complications after percutaneous nephroscopy[J/CD]. Chinese Journal of Endoscopic Urology, 2020, 15(2): 121-125. [22] KARANI R, ARADA R B, OKHUNOV Z, et al. Endoscopic guided percutaneous nephrolithotomy[J]. J Endourol, 2021, 35(S2): S62-S67. [23] DIBIANCO J M, GHANI K R. Precision stone surgery: current status of miniaturized percutaneous nephrolithotomy[J]. Curr Urol Rep, 2021, 22(4): 24. DOI: 10.1007/s11934-021-01042-0.